Joel Rosenblatt

Dr. Joel Rosenblatt


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
JRJoel Rosenblatt
Joel Rosenblatt
RRRuth Reitzel
Ruth Reitzel
TDTanya Dvorak
Tanya Dvorak
YJYing Jiang
Ying Jiang
RHRay Y. Hachem
Ray Y. Hachem
IRIssam I. Raad
Issam I. Raad
Antimicrobial catheter lock therapy is practiced to prevent lumenal-sourced infections of central venous catheters. Citrate has been used clinically as an anticoagulant in heparin-free catheter locks. Ethanol has also been widely studied as an antimicrobial lock solution component. This study reports on the synergy of glyceryl trinitrate (GTN) with citrate and ethanol in rapidly eradicating methicillin-resistant Staphylococcus aureus , methicillin-resistant Staphylococcus epidermidis , Pseudomonas aeruginosa , and Candida albicans biofilms in an in vitro model for catheter biofilm colonization. GTN has a long history of intravenous use as a hypotensive agent. It is potentially attractive as a component of a catheter lock solution because its physiologic half-life is quite short and its metabolic pathways are known. A lock containing 7% citrate and 20% ethanol required 0.01% GTN to fully eradicate biofilms of all test organisms within 2 h in the model. This GTN concentration is below the levels where clinically significant hypotensive effects are expected.

1 March 2017 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
GVGeorge M. Viola
George M. Viola
JRJoel Rosenblatt
Joel Rosenblatt
IRIssam I. Raad
Issam I. Raad

18 October 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
JRJoel Rosenblatt
Joel Rosenblatt
RRRuth A. Reitzel
Ruth A. Reitzel
NVNylev Vargas-Cruz
Nylev Vargas-Cruz
ACAnne-Marie Chaftari
Anne-Marie Chaftari
RHRay Hachem
Ray Hachem
IRIssam Raad
Issam Raad
There is a need for non-antibiotic, antimicrobial compositions with low toxicity capable of broad-spectrum eradication of pathogenic biofilms in food preparation and healthcare settings. In this study we demonstrated complete biofilm eradication within 60 min with synergistic combinations of caprylic and polygalacturonic (PG) acids in an in vitro biofilm eradication model against representative hospital and foodborne infectious pathogen biofilms (methicillin-resistant Staphylococcus aureus, multidrug-resistant Pseudomonas aeruginosa, Candida albicans, Escherichia coli, and Salmonella enteritidis). Antimicrobial synergy against biofilms was demonstrated by quantifying viable organisms remaining in biofilms exposed to caprylic acid alone, PG acid alone, or combinations of the two. The combinations also synergistically inhibited growth of planktonic organisms. Toxicity of the combination was assessed in vitro on L929 fibroblasts incubated with extracts of caprylic and PG acid combinations using the Alamar Blue metabolic activity assay and the Trypan Blue exclusion cell viability assay. The extracts did not produce cytotoxic responses relative to untreated control fibroblasts.

1 September 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
RRRuth A. Reitzel
Ruth A. Reitzel
JRJoel Rosenblatt
Joel Rosenblatt
CHCheryl Hirsh-Ginsberg
Cheryl Hirsh-Ginsberg
KMKimberly Murray
Kimberly Murray
ACAnne-Marie Chaftari
Anne-Marie Chaftari
IRIssam Raad
Issam Raad
The rapid, broad-spectrum, biofilm-eradicating activity of the combination of 0.01% nitroglycerin, 7% citrate, and 20% ethanol and its potential as a nonantibiotic, antimicrobial catheter lock solution (ACLS) were previously reported. Here, a nitroglycerin-citrate-ethanol (NiCE) ACLS optimized for clinical assessment was developed by reducing the nitroglycerin and citrate concentrations and increasing the ethanol concentration. Biofilm-eradicating activity was sustained when the ethanol concentration was increased from 20 to 22% which fully compensated for reducing the citrate concentration from 7% to 4% as well as the nitroglycerin concentration from 0.01% to 0.0015% or 0.003%. The optimized formulations demonstrated complete and rapid (2 h) eradication of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA), methicillin-resistant Staphylococcus epidermidis (MRSE), vancomycin-resistant enterococci (VRE), multidrug-resistant (MDR) Pseudomonas aeruginosa, MDR Klebsiella pneumoniae, MDR Enterobacter cloacae, MDR Acinetobacter baumannii, MDR Escherichia coli, MDR Stenotrophomonas maltophilia, Candida albicans, and Candida glabrata biofilms. The optimized NiCE lock solutions demonstrated anticoagulant activities comparable to those of heparin lock solutions. NiCE lock solution was significantly more effective than taurolidine-citrate-heparin lock solution in eradicating biofilms of Staphylococcus aureus and Candida glabrata. The optimized, nonantibiotic, heparin-free NiCE lock solution demonstrates rapid broad-spectrum biofilm eradication as well as effective anticoagulant activity, making NiCE a high-quality ACLS candidate for clinical assessment.

1 January 2014 in American Journal of Infection Control
Verified
Journal Article
Closed access
RRRuth Reitzel
Ruth Reitzel
JRJoel Rosenblatt
Joel Rosenblatt
YJYing Jiang
Ying Jiang
RHRay Hachem
Ray Hachem
IRIssam Raad
Issam Raad

1 March 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
JRJoel Rosenblatt
Joel Rosenblatt
RRRuth A. Reitzel
Ruth A. Reitzel
IRIssam Raad
Issam Raad
There is a growing need for biocompatible, broad-spectrum, nonantibiotic, antimicrobial treatments because of the frequent ineffectiveness of antibiotics against biofilms and the increasing incidence of antibiotic resistance. In this study, we demonstrate rapid and complete biofilm eradication in an in vitro model with synergistic combinations of glyceryl trinitrate and caprylic acid against resistant Gram-positive, Gram-negative, and fungal biofilms.